IBI310 drug page Clinical trials

Trials with IBI310

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
1Countries
4Planned patients

Showing 1–1 of 1

IBI310 in Combination with Sintilimab in Patients with DNA Mismatch Repair Deficient (dMMR)/microsatellite Instability High (MSI-H) Locally-advanced or Metastatic Colorectal Cancer
Finished Phase 2 4 patients NCT04258111

The main purpose of this study is to assess the efficacy and safety of IBI310 in combination with sintilimab in patients with Microsatellite Instability High (MSI-H) or Mismatch Repair Deficient (dMMR) locally advance or metastatic colorec…

China Aug 2020 – Oct 2020 Interventional
Combined with: Sintilimab